-
Nabanita Chatterjee, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
Ovarian Cancer Disrupts Circadian Cortisol Rhythms
-
Marion Curtis, PhD,
University of Chicago
Mentored Investigator Grant
Mediators of Chemosensitivity and Immunotherapy Targets
-
Anniina Farkkila, MD, PhD,
Dana Farber Cancer Institute
Mentored Investigator Grant
Overcoming PARP Inhibitor Resistance in Ovarian Cancer
-
Jagmohan Hooda, PhD,
University of Pennsylvania
Mentored Investigator Grant
Loss of H2Bub1 Rewires Glutamine Metabolism During Progression of HGSOC
-
Gilbert Huang, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
Targeting Dormant Ovarian Cancer Cells with Peptide Inhibitors of Autophagy
-
Tyler Curiel, MD,
University of Texas Health Science Center at San Antonio
Collaborative Research Development Grant
Rational Design of Effective Multi-modal Ovarian Cancer Immunotherapy
-
Dongyu Jia, PhD,
Cedars-Sinai Medical Center
Mentored Investigator Grant
COL11A Is A Highly Specific Therapeutic Target in Cancer-Activated Stroma
-
Alessia Baccarini, PhD,
Mount Sinai School of Medicine
Early Career Investigator Grant
Regulation of the Immune Checkpoint PD-L1 in Ovarian Cancer
-
Ronald Chandler, PhD,
Michigan State University
Early Career Investigator Grant
Integrated Roles of Epigenetics and Cell Signaling in Ovarian Cancer
-
Ronen Marmorstein, PhD,
University of Pennsylvania
Collaborative Research Development Grant
Chromatin Regulatory Mechanisms in Ovarian Cancer
-
Venkatesh Krishnan, PhD,
Stanford University
Mentored Investigator Grant
Omental Macrophages: Drivers of Ovarian Cancer Metastasis
-
Kenneth Nephew, PhD,
Indiana University
Collaborative Research Development Grant
Epigenetic Vulnerabilities of Ovarian Cancer Stem Cells
-
Ilana Chefetz, PhD,
University of Michigan
Early Career Investigator Grant
Drugs Inducing Necroptotic Cell Death As A New Strategy for High Grade Serous Ovarian Cancer
-
Xianzhi Lin, PhD,
Cedars-Sinai Medical Center
Mentored Investigator Grant
Systematic Discovery of LncRNA Interactome in Epithelial Ovarian Cancer
-
Ie-Ming Shih, MD, PhD,
Johns Hopkins University School of Medicine
Collaborative Research Development Grant
Development of Targeted Therapies for Recurrent Ovarian Cancer
-
Beatrice Rondinelli, PhD,
Dana Farber Cancer Institute
Mentored Investigator Grant
EZH2 Determines PARPi Resistance and Fork Stabilization in Ovarian Tumors
-
Michael Goldberg, PhD,
Dana Farber Cancer Institute
Early Career Investigator Grant
Rational Immunity to Improve Survival Following Standard-of-care Chemo
-
Priyanka Verma, PhD,
University of Pennsylvania
Mentored Investigator Grant
BRCA-Independent DNA Repair Pathways in Ovarian Cancer
-
Sunila Pradeep, PhD,
Medical College of Wisconsin
Early Career Investigator Grant
Epigenetic Causes of Acquired Resistance to Anti-VEGF Therapy
-
Boris Winterhoff, MD,
University of Minnesota Twin Cities
Early Career Investigator Grant
Precision Medicine in Ovarian Cancer: Using Single Cell Analysis